Antonio Ojea

Vigo, GA, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Long-term outcome of adjustable transobturator male system for stress urinary incontinence in the Iberian multicentre study.

Long-term outcome of adjustable transobturator male system for stress urinary incontinence in the Iberian multicentre study.

Journal: Neurourology and urodynamics

Published: April 20, 2020

Patient satisfaction with adjustable transobturator male system in the Iberian multicenter study.

Patient satisfaction with adjustable transobturator male system in the Iberian multicenter study.

Journal: World journal of urology

Published: November 25, 2018

Correction: Lifestyle factors and oncogenic papillomavirus infection in a high-risk male population.

Correction: Lifestyle factors and oncogenic papillomavirus infection in a high-risk male population.

Journal: PloS one

Published: May 08, 2018

Adjustable transobturator male system (ATOMS®) as treatment of stress urinary incontinence secondary to transurethral resection of the prostate.

Adjustable transobturator male system (ATOMS®) as treatment of stress urinary incontinence secondary to transurethral resection of the prostate.

Journal: Actas urologicas espanolas

Published: March 09, 2018

Treatment of male stress urinary incontinence with the adjustable transobturator male system: Outcomes of a multi-center Iberian study.

Treatment of male stress urinary incontinence with the adjustable transobturator male system: Outcomes of a multi-center Iberian study.

Journal: Neurourology and urodynamics

Published: September 20, 2017

Lifestyle factors and oncogenic papillomavirus infection in a high-risk male population.

Lifestyle factors and oncogenic papillomavirus infection in a high-risk male population.

Journal: PloS one

Published: February 11, 2017

Prevalence and concordance of high-risk papillomavirus infection in male sexual partners of women diagnosed with high grade cervical lesions.

Prevalence and concordance of high-risk papillomavirus infection in male sexual partners of women diagnosed with high grade cervical lesions.

Journal: Enfermedades infecciosas y microbiologia clinica

Published: October 28, 2015

Maintenance Therapy with 3-monthly Bacillus Calmette-Guérin for 3 Years is Not Superior to Standard Induction Therapy in High-risk Non-muscle-invasive Urothelial Bladder Carcinoma: Final Results of Randomised CUETO Study 98013.

Maintenance Therapy with 3-monthly Bacillus Calmette-Guérin for 3 Years is Not Superior to Standard Induction Therapy in High-risk Non-muscle-invasive Urothelial Bladder Carcinoma: Final Results of Randomised CUETO Study 98013.

Journal: European urology

Published: November 08, 2014

Sequential combination of mitomycin C plus bacillus Calmette-Guérin (BCG) is more effective but more toxic than BCG alone in patients with non-muscle-invasive bladder cancer in intermediate- and high-risk patients: final outcome of CUETO 93009, a randomized prospective trial.

Sequential combination of mitomycin C plus bacillus Calmette-Guérin (BCG) is more effective but more toxic than BCG alone in patients with non-muscle-invasive bladder cancer in intermediate- and high-risk patients: final outcome of CUETO 93009, a randomized prospective trial.

Journal: European urology

Published: April 10, 2014

Showing 1-9 of 9

Last Updated: 09/26/2026